Lipid-lowering PCSK9 sequence variants protect against coronary heart disease

@article{2006LipidloweringPS,
  title={Lipid-lowering PCSK9 sequence variants protect against coronary heart disease},
  author={},
  journal={Nature Clinical Practice Cardiovascular Medicine},
  year={2006},
  volume={3},
  pages={350-350}
}
Warfarin considerably reduces the risk of recurrent stroke in patients who have had an ischemic stroke and are in atrial fibrillation (AF). Researchers in New Zealand have investigated the reasons why, despite the proven benefits, only about 50% of patients with AF are started on warfarin therapy following ischemic stroke. The analysis included 93 patients (mean age 80 years) admitted to Auckland City Hospital with ischemic stroke and either permanent or paroxysmal AF. The diagnosis of AF was… CONTINUE READING